Holen Sie sich die Stockscreener-App
0.3876
7.27%
-0.0304
Handel nachbörslich:
.37
-0.0176
-4.54%
Schlusskurs vom Vortag:
$0.418
Offen:
$0.3147
24-Stunden-Volumen:
4.71M
Relative Volume:
1.35
Marktkapitalisierung:
$2.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.00M
KGV:
-0.337
EPS:
-1.15
Netto-Cashflow:
$-3.85M
1W Leistung:
+72.27%
1M Leistung:
+5.30%
6M Leistung:
-39.06%
1J Leistung:
-76.51%
1-Tages-Spanne:
$0.2853
$0.39
1-Wochen-Bereich:
$0.179
$0.618
52-Wochen-Spanne:
$0.179
$1.87
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Firmenname
Protagenic Therapeutics Inc
Sektor
Branche
Telefon
(212) 994-8200
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie PTIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.3876 | 2.11M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
Protagenic Therapeutics, Inc.\new SEC 10-K Report - TradingView
PTIX stock plunges to 52-week low, hitting $0.23 - Investing.com India
PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia
Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World
BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews
PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada
Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa
Protagenic Therapeutics adjusts stock option prices - Investing.com India
Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire
PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice - ACCESS Newswire
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results - ACCESS Newswire
Protagenic Therapeutics Announces Date of Annual Shareholder Meeting - ACCESS Newswire
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - ACCESS Newswire
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split - ACCESS Newswire
Performance Tech Stock Hits 52-Week Low at $0.44 Amid Market Challenges - Investing.com
Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement - Defense World
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
PTIX stock touches 52-week low at $0.45 amid market challenges - Investing.com Nigeria
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Protagenic Therapeutics (NASDAQ:PTIX) Faces Delisting Threat from NasdaqUnited States Securities and Exchange CommissionWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934D - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Galapagos NV (GLPG) Stock Surges Amid Strong Industry Performanc - GuruFocus.com
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Raises $1.27M in Private Placement with Warrant Offerings | PTIX Stock News - StockTitan
Protagenic Therapeutics Raises $1.275M for Growth Initiatives - TipRanks
Protagenic Therapeutics Secures $1.275M in Private Placement - TipRanks
Protagenic Therapeutics announces $1.275 million stock sale By Investing.com - Investing.com Canada
Protagenic Therapeutics announces $1.275 million stock sale - Investing.com
Protagenic Therapeutics to sell 1.95M shares at 64c in private placement - TipRanks
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
PTIX stock touches 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
PTIX stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):